Krishnapriya Nawal - Mangalam Drugs Chief Officer
| MANGALAM | 76.01 3.69 4.63% |
Executive
Krishnapriya Nawal is Chief Officer of Mangalam Drugs And
| Age | 40 |
| Phone | 91 22 6261 6200 |
| Web | https://www.mangalamdrugs.com |
Mangalam Drugs Management Efficiency
Mangalam Drugs' management efficiency ratios could be used to measure how well Mangalam Drugs manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| D Swathi | Apollo Sindoori Hotels | N/A | |
| Mugdha Mahambrey | Chalet Hotels Limited | N/A | |
| Piyush Shah | Dc Infotech And | 47 | |
| Kallol Kundu | EIH Associated Hotels | 52 | |
| J Suresh | EIH Associated Hotels | 60 | |
| Deepesh Joishar | Advani Hotels Resorts | 40 | |
| M Meyyappan | Apollo Sindoori Hotels | 55 | |
| Diwaker Dinesh | ITCHOTELS | 38 | |
| Christabelle Baptista | Chalet Hotels Limited | 45 | |
| Suborna Biswas | Chalet Hotels Limited | N/A | |
| Rachit Gupta | Chalet Hotels Limited | N/A | |
| Iqbal Hassan | Advani Hotels Resorts | 44 | |
| Tejasvi Dixit | EIH Associated Hotels | N/A | |
| Suresh | Apollo Sindoori Hotels | 57 | |
| Hemant Auti | Pritish Nandy Communications | N/A | |
| Ajay Vichare | Advani Hotels Resorts | 54 | |
| Kishor Palkar | Pritish Nandy Communications | N/A | |
| S Nithyanandam | Apollo Sindoori Hotels | N/A | |
| Amitava Paul | Advani Hotels Resorts | 43 | |
| Prasad Kanoth | Advani Hotels Resorts | 64 | |
| Krishna N | Chalet Hotels Limited | 62 | |
Management Performance
| Return On Equity | -0.0631 | ||||
| Return On Asset | 0.005 |
Mangalam Drugs And Leadership Team
Elected by the shareholders, the Mangalam Drugs' board of directors comprises two types of representatives: Mangalam Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mangalam. The board's role is to monitor Mangalam Drugs' management team and ensure that shareholders' interests are well served. Mangalam Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mangalam Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brijmohan Dhoot, WholeTime Director | ||
| Kamal Vashi, President | ||
| Krishnapriya Nawal, Chief Officer | ||
| Govardhan Dhoot, Chairman MD | ||
| Anuradha Pandey, Company Officer | ||
| Mansi Pathak, Senior Manager | ||
| Bhanvesh Naik, General Manager | ||
| Jayant Barde, Company Officer | ||
| Ajay Samant, Chief Officer | ||
| Rakesh Srivastava, General Manager | ||
| Yaduraj Dhoot, Head Purchase |
Mangalam Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mangalam Drugs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0631 | ||||
| Return On Asset | 0.005 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 1.95 B | ||||
| Shares Outstanding | 15.83 M | ||||
| Shares Owned By Insiders | 54.58 % | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 0.36 X | ||||
| Revenue | 3.67 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Mangalam Stock
Mangalam Drugs financial ratios help investors to determine whether Mangalam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mangalam with respect to the benefits of owning Mangalam Drugs security.